Bortezomib provides favorable efficacy in type 3 acquired von willebrand syndrome related to lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia. Issue 2 (28th January 2022) - Kong, Danqing; Li, Yun; Fu, Chengcheng; Hou, Mengjia; Yan, Lingzhi; Shang, Jingjing; Wang, Zhaoyue; Yin, Jie; Yu, Ziqiang; Wu, Depei